Axiom Investment Management’s Gilead Sciences GILD Stock Holding History

Axiom Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$677K	Buy	+4,858	New	+$680K	0.52%	47
2022 Q4	$618K	Sell	7,195 -3,819	-35%	-$302K	1.61%	14
2022 Q3	$679K	Sell	11,014 -2,249	-17%	-$142K	1.36%	16
2022 Q2	$819K	Sell	13,263 -45,445	-77%	-$2.81M	2.35%	10
2022 Q1	$3.49M	Sell	58,708 -4,063	-6%	-$260K	7.59%	1
2021 Q4	$4.56M	Sell	62,771 -9,906	-14%	-$682K	4.42%	5
2021 Q3	$5.08M	Buy	72,677 +2,337	+3%	+$164K	5.1%	3
2021 Q2	$4.84M	Buy	70,340 +17,207	+32%	+$1.15M	3.76%	6
2021 Q1	$3.44M	Buy	53,133 +52,611	+10,079%	+$3.39M	2.8%	7
2020 Q4	$1.21K	Buy	+522	New	+$31.5K	1.1%	25
2020 Q2	–	Sell	-3,142	Closed	-$236K	–	131
2020 Q1	$236K	Buy	+3,142	New	+$217K	0.42%	68
2019 Q4	–	Sell	-3,292	Closed	-$208K	–	171
2019 Q3	$208K	Sell	3,292 -3,959	-55%	-$259K	0.16%	154
2019 Q2	$491K	Sell	7,251 -586	-7%	-$38.5K	0.09%	222
2019 Q1	$510K	Buy	7,837 +1,507	+24%	+$100K	0.1%	216
2018 Q4	$396K	Buy	+6,330	New	+$442K	0.08%	215

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Axiom Investment Management's GILD Position: Q1 2026 in Review

Axiom Investment Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 4,858 shares worth $677K. The stake represents 0.52% of the portfolio and ranks #47 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in GILD as recently as Q4 2022.

Axiom Investment Management first reported a position in GILD in Q4 2018 and has held it in 15 quarters since. The position peaked at $5.08M in Q3 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Axiom Investment Management held 4,858 shares of Gilead Sciences worth $677K as of Q1 2026.
Gilead Sciences was a new Axiom Investment Management position in Q1 2026.
Gilead Sciences made up 0.52% of Axiom Investment Management's portfolio in Q1 2026, its #47 holding.
Axiom Investment Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 15 quarters since.
Axiom Investment Management's Gilead Sciences position peaked at $5.08M in Q3 2021.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Axiom Investment Management's 13F filing for Q1 2026, filed 26 May 2026.